Some patients may find that Tirzepatide has fewer or more manageable side effects than Semaglutide
Efficacy and safety of once-weekly glucagon-like peptide 1 receptor agonist albiglutide (HARMONY 1 trial): 52-week primary endpoint results from a randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes mellitus not controlled on pioglitazone, with or without metformin
EMBO J 22:26232633 Law MY, Charles SA, Halliwell B (1983) Glutathione and ascorbic acid in spinach ( Spinacia oleracea ) chloroplasts
Firstly, the dosage varies significantly
Moreover, several studies have demonstrated that semaglutide lowers the incidence of major cardiovascular events (cardiovascular death, heart attack, or stroke) in people with obesity or type 2 diabetes
I have also written about the immune benefits of beta-glucan in these blogs